Vineti is the first commercial cloud-based platform to expand patient access to life-saving cell and gene therapies. Vineti was co-founded by GE and the Mayo Clinic to solve the key challenges patients, medical providers, biopharmaceutical companies and regulators face in the delivery and commercialization of 21st century medicine. The Vineti platform integrates logistics, manufacturing and clinical data to improve product performance overall. Caregivers and pharmaceutical pioneers are empowered to help more patients more effectively and safely, treatments are better understood and improved over time, and most importantly, there's an opportunity to provide greater health outcomes-and cures-to patients in need.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/23/17 | $13,750,000 | Series A |
DFJ GE Ventures LifeForce Capital Mayo Clinic Ventures | undisclosed |
| 02/07/20 | $33,500,000 | Series B |
Canaan Partners Casdin Capital DFJ GE Ventures LifeForce Capital Section 32 | undisclosed |
| 10/17/20 | $33,000,000 | Series C Extension |
Canaan Partners Cardinal Health Casdin Capital LifeForce Capital Marc Benioff McKesson Ventures Novartis Venture Funds Section 32 Threshold Ventures | undisclosed |
